Cetera Investment Advisers
VYGR icon

Cetera Investment Advisers’s Voyager Therapeutics VYGR Stock Holding History

Cetera Investment Advisers’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72.4K Buy
20,699
+6,435
+45% +$24.4K ﹤0.01% 4721
2026
Q1 		$55.1K Buy
14,264
+100
+0.7% +$394 ﹤0.01% 4568
2025
Q4 		$55.7K Hold
14,164
– – ﹤0.01% 4491
2025
Q3 		$66.1K Buy
+14,164
New +$51.2K ﹤0.01% 4397

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Cetera Investment Advisers's VYGR Position: Q2 2026 in Review

Cetera Investment Advisers increased its Voyager Therapeutics (VYGR) stake by 45% in Q2 2026, buying an estimated $24.4K and bringing the position to 20,699 shares worth $72.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4721.

Cetera Investment Advisers first reported a position in VYGR in Q3 2025 and has held it in 4 quarters since. 135 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Cetera Investment Advisers held 20,699 shares of Voyager Therapeutics worth $72.4K as of Q2 2026.
  • Cetera Investment Advisers bought 6,435 Voyager Therapeutics shares in Q2 2026, an estimated $24.4K.
  • Voyager Therapeutics made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4721 holding.
  • Cetera Investment Advisers first reported a position in Voyager Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.